# Windlas Healthcare Private Limited, Dehradun, India – FDA Inspections

Source: https://www.keypedia.com/companies/windlas-healthcare-private-limited/1cf912ba-dbe9-4b74-ba3c-a7bc0bd8678f

> Inspection records and compliance data for Windlas Healthcare Private Limited in Dehradun. 5 FDA inspections on record (1 OAI), 2 Form 483s, last inspected August 30, 2019.

---

## Details

- Name: Windlas Healthcare Private Limited
- FEI Number: 3005339091
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: Plot No 183 & 192 Mohabewala Industrial
- City: Dehradun
- Country Name: India
- Address: Plot No 183 & 192 Mohabewala Industrial, Dehradun, India
- Country: India

## Related Documents

- [483 - Windlas Healthcare Private Limited - 2019-08-30](https://www.keypedia.com/records/483/windlas-healthcare-private-limited/eeb90f4e-bc15-4ba4-beb7-68250040de8b) — source: FDA, date: August 30, 2019
- [FDA Inspection 1101210 - Windlas Healthcare Private Limited - 2019-08-30](https://www.keypedia.com/records/fda_inspections/windlas-healthcare-private-limited/d4858c1b-f893-4957-948e-2fe45f28af48) — classification: Official Action Indicated (OAI), source: FDA, date: August 30, 2019
- FDA Inspection 1101210 - Windlas Healthcare Private Limited - 2019-08-30 — classification: Official Action Indicated (OAI), source: FDA, date: August 30, 2019
- [FDA Inspection 1055378 - Windlas Healthcare Private Limited - 2018-06-01](https://www.keypedia.com/records/fda_inspections/windlas-healthcare-private-limited/2a4f2a4b-c22a-4b88-a902-cbabc5fe252a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2018
- FDA Inspection 1023197 - Windlas Healthcare Private Limited - 2017-07-21 — source: FDA, date: July 21, 2017
- FDA Inspection 962641 - Windlas Healthcare Private Limited - 2016-02-17 — classification: No Action Indicated (NAI), source: FDA, date: February 17, 2016
- FDA Inspection 882841 - Windlas Healthcare Private Limited - 2014-06-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 13, 2014

## Related Companies

- [Fresenius Kabi Oncology Limited](https://www.keypedia.com/companies/fresenius-kabi-oncology-limited/d092c98c-aa35-490f-97c4-3ed02fe7dac7)
- [Upsher-Smith Laboratories, LLC](https://www.keypedia.com/companies/upsher-smith-laboratories-llc/abe71588-9a29-43ec-9663-eabd373c78c5)
- [Ascend Laboratories, LLC](https://www.keypedia.com/companies/ascend-laboratories-llc/13da97c0-bcd0-4d01-9c02-8a46b089cfc5)
- [Arifulla Khan MD](https://www.keypedia.com/companies/arifulla-khan-md/311edd91-40e3-4296-9283-8ea2b60de005)
- [Amneal Pharmaceuticals, Llc](https://www.keypedia.com/companies/amneal-pharmaceuticals-llc/1727fcb2-2120-4a7c-a93b-a52aa106268f)
- [Imaging Endpoints II, LLC.](https://www.keypedia.com/companies/imaging-endpoints-ii-llc/fcd4f5a9-856c-404f-b6f1-0fa2cb3c88f7)
- [Dario D. Altamirano, DO](https://www.keypedia.com/companies/dario-d-altamirano-do/3edb2aaf-26c5-417d-bd2a-35cb8d56cfc2)
- [Dakhil, Dr Shaker](https://www.keypedia.com/companies/dakhil-dr-shaker/ff880691-4af7-4e7b-ac3d-7c9c33c6bc2a)
- [Novo Nordisk A/S](https://www.keypedia.com/companies/novo-nordisk-as/c57b9a63-64b0-49c3-acb3-64866f304d30)
- [Andrew C Sedillo, MD](https://www.keypedia.com/companies/andrew-c-sedillo-md/4d92fceb-05ed-4140-ab2f-36edf0630a9f)

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)
- [Pratik S. Upadhyay](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)